Clinical Trials In Plainfield

Discover hundreds of clinical trials in Plainfield.
Search clinical trials in Plainfield by condition or phase.

e.g. Respiratory Diseases

Plainfield•Healthy volunteers: No

Filter results

Results: 2,260

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT

Recruiting

Phase 2

Sponsor:

Mercator MedSystems, Inc.

Location:

Chicago, Darien, Tampa, Houmashow 9 more

Code:

NCT04858776

Conditions

Iliofemoral; Thrombosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Perivascular dexamethasone

Perivascular sham

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting

Phase 3

Sponsor:

AbbVie

Location:

Skokie, Schaumburg, Rockford, Libertyvilleshow 69 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis

Recruiting

Phase 3

Sponsor:

AstraZeneca

Location:

Normal, Chicago, Phoenix, Little Rockshow 24 more

Code:

NCT05583227

Conditions

Eosinophilic Esophagitis

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

Tezepelumab

Placebo

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

Recruiting

Phase 3

Sponsor:

Pfizer

Location:

Morton Grove, Libertyville, Lake Bluff, Gurneeshow 92 more

Code:

NCT04173273

Conditions

Crohn's Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Placebo

Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers

Recruiting

Phase 3

Sponsor:

Intercytex

Location:

Springfield, North Chicago, Niles, Montgomeryshow 25 more

Code:

NCT00232973

Conditions

Leg Ulcer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ICXP007

Perturbation Training for Fall-risk Reduction Among Stroke Survivors

Recruiting

Sponsor:

University of Illinois at Chicago

Location:

Chicago

Code:

NCT03205527

Conditions

Stroke

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

Overground slip perturbation training

Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence

Recruiting

Sponsor:

NICHD Pelvic Floor Disorders Network

Location:

Chicago, La Jolla, San Diego, Durhamshow 3 more

Code:

NCT06480227

Conditions

Stress Urinary Incontinence

Urinary Incontinence

Mixed Urinary Incontinence

Eligibility Criteria

Sex: Female

Age: 21+

Healthy Volunteers: Not accepted

Interventions

Solyx Single-incision Sling

Bulkamid Transurethral Bulking Agent

A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004

Recruiting

Phase 3

Sponsor:

Intec Pharma Ltd.

Location:

Chicago, Birmingham, Phoenix, Sun Cityshow 32 more

Code:

NCT02615873

Conditions

Parkinson's Disease

Eligibility Criteria

Sex: All

Age: 30 - 70+

Healthy Volunteers: Not accepted

Interventions

Accordion Pill™ Carbidopa/Levodopa

JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors

Recruiting

Phase 1

Phase 2

Sponsor:

Jacobio Pharmaceuticals Co., Ltd.

Location:

Chicago, Phoenix, Scottsdale, Los Angelesshow 11 more

Code:

NCT04720976

Conditions

Solid Tumor

NSCLC

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

JAB-3312

Binimetinib

Pembrolizumab

Sotorasib

Osimertinib

A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)

Recruiting

Sponsor:

Sanofi

Location:

Chicago, Cincinnati, Columbus, Philadelphia

Code:

NCT06192576

Conditions

Niemann-Pick Diseases

Acid Sphingomyelinase Deficiency

Eligibility Criteria

Sex: All

Age: 0 - 2

Healthy Volunteers: Not accepted

Interventions

Olipudase alfa

e.g. Respiratory Diseases

Plainfield•Healthy volunteers: No

Filter results

Results: 2,260

Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thrombus Removal to Yield Benefit in Subacute and Chronic Iliofemoral DVT

Recruiting

Phase 2

Sponsor:

Mercator MedSystems, Inc.

Location:

Chicago, Darien, Tampa, Houmashow 9 more

Code:

NCT04858776

Conditions

Iliofemoral; Thrombosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Perivascular dexamethasone

Perivascular sham

Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis

Recruiting

Phase 3

Sponsor:

AbbVie

Location:

Skokie, Schaumburg, Rockford, Libertyvilleshow 69 more

Code:

NCT05814627

Conditions

Rheumatoid Arthritis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Adalimumab

Upadacitinib Matching Placebo

Adalimumab Matching Placebo

Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis

Recruiting

Phase 3

Sponsor:

AstraZeneca

Location:

Normal, Chicago, Phoenix, Little Rockshow 24 more

Code:

NCT05583227

Conditions

Eosinophilic Esophagitis

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

Tezepelumab

Placebo

A Study Evaluating the Efficacy and Safety of Oral Etrasimod in the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease

Recruiting

Phase 3

Sponsor:

Pfizer

Location:

Morton Grove, Libertyville, Lake Bluff, Gurneeshow 92 more

Code:

NCT04173273

Conditions

Crohn's Disease

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Etrasimod

Placebo

Safety and Efficacy Study of ICXP007 With Compression Bandaging for the Treatment of Non-Infected Venous Leg Ulcers

Recruiting

Phase 3

Sponsor:

Intercytex

Location:

Springfield, North Chicago, Niles, Montgomeryshow 25 more

Code:

NCT00232973

Conditions

Leg Ulcer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

ICXP007

Perturbation Training for Fall-risk Reduction Among Stroke Survivors

Recruiting

Sponsor:

University of Illinois at Chicago

Location:

Chicago

Code:

NCT03205527

Conditions

Stroke

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

Overground slip perturbation training

Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence

Recruiting

Sponsor:

NICHD Pelvic Floor Disorders Network

Location:

Chicago, La Jolla, San Diego, Durhamshow 3 more

Code:

NCT06480227

Conditions

Stress Urinary Incontinence

Urinary Incontinence

Mixed Urinary Incontinence

Eligibility Criteria

Sex: Female

Age: 21+

Healthy Volunteers: Not accepted

Interventions

Solyx Single-incision Sling

Bulkamid Transurethral Bulking Agent

A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004

Recruiting

Phase 3

Sponsor:

Intec Pharma Ltd.

Location:

Chicago, Birmingham, Phoenix, Sun Cityshow 32 more

Code:

NCT02615873

Conditions

Parkinson's Disease

Eligibility Criteria

Sex: All

Age: 30 - 70+

Healthy Volunteers: Not accepted

Interventions

Accordion Pill™ Carbidopa/Levodopa

JAB-3312 Based Combination Therapy in Adult Patients With Advanced Solid Tumors

Recruiting

Phase 1

Phase 2

Sponsor:

Jacobio Pharmaceuticals Co., Ltd.

Location:

Chicago, Phoenix, Scottsdale, Los Angelesshow 11 more

Code:

NCT04720976

Conditions

Solid Tumor

NSCLC

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

JAB-3312

Binimetinib

Pembrolizumab

Sotorasib

Osimertinib

A Real-world Long-term Safety and Immunogenicity Study of Olipudase Alfa Therapy in Pediatric Patients Less Than 2 Years of Age With Acid Sphingomyelinase Deficiency (ASMD)

Recruiting

Sponsor:

Sanofi

Location:

Chicago, Cincinnati, Columbus, Philadelphia

Code:

NCT06192576

Conditions

Niemann-Pick Diseases

Acid Sphingomyelinase Deficiency

Eligibility Criteria

Sex: All

Age: 0 - 2

Healthy Volunteers: Not accepted

Interventions

Olipudase alfa